Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

What containment strategy leads us through the pandemic crisis? An empirical analysis of the measures against the COVID-19 pandemic

What containment strategy leads us through the pandemic crisis? An empirical analysis of the measures against the COVID-19 pandemic

  • Daniel Kaimann, 
  • Ilka Tanneberg


Since January 2020, the COVID-19 outbreak has been progressing at a rapid pace. To keep the pandemic at bay, countries have implemented various measures to interrupt the transmission of the virus from person to person and prevent an overload of their health systems. We analyze the impact of these measures implemented against the COVID-19 pandemic by using a sample of 68 countries, Puerto Rico and the 50 federal states of the United States of America, four federal states of Australia, and eight federal states of Canada, involving 6,941 daily observations. We show that measures are essential for containing the spread of the COVID-19 pandemic. After controlling for daily COVID-19 tests, we find evidence to suggest that school closures, shut-downs of non-essential business, mass gathering bans, travel restrictions in and out of risk areas, national border closures and/or complete entry bans, and nationwide curfews decrease the growth rate of the coronavirus and thus the peak of daily confirmed cases. We also find evidence to suggest that combinations of these measures decrease the daily growth rate at a level outweighing that of individual measures. Consequently, and despite extensive vaccinations, we contend that the implemented measures help contain the spread of the COVID-19 pandemic and ease the overstressed capacity of the healthcare systems.


The first reported and confirmed case of the novel COVID-19 pneumonia COVID-19 and its causative virus, SARS-CoV-2, was reported in Wuhan, China, on December 31, 2019 [1]. As of May 24, 2020, there have been 5,418,000 total confirmed cases of SARS-CoV-2 infections worldwide in 188 countries, including 344,742 deaths [2], and the outbreak is continuing at exponential growth [3]. At the beginning of January, first studies have suggested the likelihood of travel-related risks regarding the regional and global spread of the coronavirus [4]. Bogoch et al. [5] have stated that "the current outbreak in Wuhan, China serves as a reminder of how rapidly novel pathogens can appear and spread with potentially serious global consequences. Although it is unclear what the current burden of disease is or the potential for human-to-human transmission, major Asian hubs are the most probable sites of exportation should this epidemic continue […]".

Consequently, to keep the pandemic at bay, measures that limit population mobility and within-population contact rates should be considered in affected areas [4]. These include school closures, bans of gatherings, work-from-home covenants, and the most draconian measure, curfews, and total system shut-downs. This concept is also known as "flattening the curve", which involves decreasing and delaying an epidemic’s peak to avoid overstressing the capacity of healthcare systems [6]. During the ongoing pandemic with its persistent increases of new coronavirus infections, highly recurrent updates, even daily, on clinical outcomes and laboratory test results are crucially important for controlling public health planning both domestically and internationally [7, 8].

Since the outbreak of the SARS-CoV-2 pandemic, countries have implemented various measures to interrupt the transmission of the virus from person to person and prevent an overload of the health system. To name a few, India, China, France, Italy, New Zealand, Poland, Denmark, Austria, Germany, Spain, and the UK have established restrictive regulations on travel and private movement, placing a third of the global population in a coronavirus quarantine [9]. The implemented measures differ in their extent of restrictions for public and economic life, varying from school and business closures, travel entry restrictions, bans of gatherings, to national quarantines. For example, since March 17, 2020, France has been on a total lockdown, with all non-essential gatherings and excursions from home banned [10].

We aim to analyze the impact of such measures and combinations of these measures against the proliferation of the COVID-19 disease. Accordingly, we aim to address the following specific research questions:

  1. How do the different types of measures affect the containment of the spread of the COVID-19 pandemic?
  2. How do different combinations of measures help against the proliferation of the SARS-CoV-2 virus?


To analyze the impact of implemented measures against the COVID-19 pandemic, we use a sample of 68 countries, Puerto Rico and the 50 federal states of the United States of America, four federal states of Australia, and eight federal states of Canada, involving 6,941 daily observations between January 22 and May 24, 2020. Each country observation starts from the first confirmed case and ends either on May 24 or when one measure was first lifted. A list of the countries and states with their observed periods can be found in Table 1. This data has been obtained from the John Hopkins Coronavirus Resource Center [11], which combine data sources from the World Health Organization, the Centers for Disease Control and Prevention, the European Centre for Disease Prevention and Control, 1point3acres,, Breaking News On, state and national government health departments, and local media reports.

Table 1. Countries and states and their observed periods.

We test the effect of six different implemented measures on the containment of the SARS-CoV-2 virus: namely, school closures, shut-downs of non-essential businesses, mass gathering bans, travel restrictions in and out of risk areas, national border closures and/or complete entry bans, and nationwide curfews. The country and state governments and local health authorities have provided the type and timing of implemented measures. Most countries implement more than one measure simultaneously, so we also analyze combinations of the measures mentioned above and include the five most commonly implemented combinations and even one combination that consists of all other combinations. A summary of the key descriptives, the combinations of measures, and control variables can be found in Table 2.

Considering this diverse number of countries might be challenging as the number of cases can vary widely between countries and states over time due to differences in the cases’ definition, testing strategies, and reporting chain. In general, cases are categorized into three different levels: suspected, probable, and confirmed cases [12]. A suspected case shows clinical signs and symptoms of having COVID-19; a probable case has been in close contact with a positive case or a COVID-19-affected area; a confirmed case has laboratory confirmation of COVID-19 [12]. Our data include confirmed and probable cases that countries and states have stated. In addition, the definition of cases might change over time and results in abnormal spikes in the data. For example, France and some of the federal states of the United States of America add probable cases to their reporting in the observed period. France has included probable cases from nursing homes on April 12th [13], leading to an exponential increase of 26,849 cases on one single day.

Farther, the variation of total cases might be a result of different testing of COVID-19. The number of performed tests can be seen as an upper limit for the number of confirmed cases [14]. Therefore, a low number of tests can result in a low number of confirmed cases. The positive rate of tests can also vary by testing strategies. In the early phase of the pandemic, the resources of testing have been limited. Thus, the WHO recommends a prioritization that should focus on the early identification and protection of vulnerable patients and health care workers [15]. With growing testing capacity, the testing strategies shift to the prioritization of suspectable cases [15]. Still, this excludes the group of asymptomatic cases. Different studies (overview see [16]) show that asymptomatic cases can account for approximately 4% to 40% of the total cases. Concluding, a more comprehensive testing strategy can improve and increase case ascertainment [17].

In addition, the incubation period of a COVID-19 disease affects and probably delays the introduced measures to decelerate the proliferation of the SARS-CoV-2 virus. Thus, there is a difference between the actual reporting of a case and its infection (e.g., incubation period, plus time to seek testing, plus time to result and report). Lauer et al. [18] show that the incubation time can vary between 2 and 14 days, with an average of 5.1 days.

However, Lee et al. [19] have shown the superiority of predictive accuracy and data integration from multiple countries compared to individual country-based COVID-19 spread models. Following Lee et al. [19], we have built a comprehensive dataset to shed light on the impact of the different measures against the COVID-19 pandemic across countries based on improved models and declaration of variances. In addition, we have improved and extended our data description, focusing on the differences across countries and their data collection strategies. We have also included daily testing numbers across countries to account for testing bias that may affect the actual effects of the implemented restrictions. We have further integrated three indexes from the Global Health Security (GHS) to account for the reporting and investigation processes that can vary by country. The GHS Index is the comprehensive assessment and benchmarking of health security and related capabilities across 195 countries. The GHS Index is a Nuclear Threat Initiative (NTI) and Johns Hopkins Center for Health Security (JHU) project. In particular, we have included the following sub-indexes to our analyses:

  1. Detection and Reporting: Early detection and reporting for epidemics of potential international concern
  2. Rapid Response: Rapid response to and mitigation of the spread of an epidemic
  3. Health System: Sufficient and robust health system to treat the sick and protect health workers

Following Lauer et al. [18], Li et al. [20], and Linton et al. [21], we have also included different incubation times to account for the difference between the report and the actual infection of COVID-19 cases. All studies have certain incubation times in common. For example:

  • The minimum incubation time is approximately 2 days
  • The average incubation time is approximately 5 days
  • The 95 percentiles of the incubation time are approximately 11 days
  • The maximum incubation time is approximately 15 days

We account for these incubation times and additionally include an incubation time of 8 days in our analyses. Therefore, we can account for the mean incubation of COVID-19 and control for possible additional time to seek testing, time to results, and/or time to report. We additionally control for the country sizes by including the population of each country and state.


We use the nonlinear mixed-effect model to analyze the relationship between the measures against the COVID-19 pandemic and the cumulated number of confirmed COVID-19 cases. The method is widely used for different epidemics such as influenza [2224], hospital-acquired infections [25], HIV/AIDS [26], and SARS-CoV-2 [19, 27]. Nonlinear mixed-effect models outperform individual models by integrating information from different subjects to increase the predictive power for the individual [19]. It considers both random and fixed effects. Random effects allow the estimation of variance in the response variable within and among groups of variables [28]. We assume that observations of one country and state are closer to each other than those of other countries and states. Consequently, country and state are the grouping variables in our study. Fixed effects are represented by the predictor variables, which include the containment measures and the control variables.

An additional advantage of the nonlinear mixed-effect model is the assumption of nonlinearity. Following Kamrujjaman et al. [29], Liang [30], and Roosa et al. [31], we also consider a logistic growth curve of the COVID-19 pandemic. The adjusted R2 of the logistic function is 98,05%, meaning that we have a nearly perfect overall fit of the represented logistic growth curve to our data (see Fig 1), which consists of three parameters, namely the upper asymptote, growth rate, and inflection point. In our analysis, the upper asymptote represents the final epidemic size. The growth rate represents the infection rate and, therefore, the speed of the spread. The inflection point represents the lag phase of the infection trajectory with the time point of daily cases’ peak [19].

As the logistic growth curve assumes that the pandemic follows the same logistic function in all observed countries and states, the expected cumulated number of confirmed cases over time will indeed differ to a certain degree, thus also affecting the expected inflection point and growth rate of the coronavirus outbreak. We account for these differences with random intercepts for the parameters (described in Eqs (2)(4)). Following Bates and Pinheiro [32], we test the integration of random intercepts in the nonlinear mixed-effect model using the Akaike information criterion (AIC). We note that these information criteria suggest the inclusion of random intercepts for all three parameters: namely, the upper asymptote, growth rate, and inflection point. Thus, the model is represented by (1) with (2) (3) (4)

Eq (1) specifies the logistic function for each country or state i at time j. Yij is the number of cumulated confirmed cases at time j for each country or state i. β1j presents the upper asymptote (maximum size reached after an infinite growing time), β2j shows the growth rate, and β3j the time of the inflection point. εij is the Gaussian error term of country or state i at time j.

Eqs (2)(4) define the nonlinear mixed-effect model parameters at time j. β10, β20, and β30 are the fixed intercepts representing the mean estimates of the parameters. u1j, u2j, and u3j represent the respective random intercepts for each country or state over time j. They account for the deviation of each country or state from the sample mean. The predictor variables are represented by the measures vector, including school closures, shut-downs of non-essential businesses, mass gathering bans, travel restrictions in and out of risk areas, national border closures and/or complete entry bans, and nationwide curfews. We also analyze the six most commonly implemented combinations of these individual measures. All analyses contain the control variables, which have been mean-centered [33, 34]. In addition, the control variables population and daily tests have been logarithmized.


Table 3 summarizes the estimations of the relationship between the measures and the confirmed coronavirus cases. Table 4 includes combinations of these measures to analyze the interactions between the measures and the cumulated confirmed COVID-19 cases. Nonlinear mixed-effect estimations are shown, representing the model outlined in Eqs (1)(4). We estimate the parameters of the upper asymptote, growth rate, and time of the inflection point. The constants of the three parameters present the mean values without any implemented measures and at the mean of the control variables. Both tables include five models representing different reporting and incubation time lags.

Table 3. Nonlinear mixed-effect regression results of the individual measures.

Table 4. Nonlinear mixed-effect regression results of the combinations of individual measures.

The individual measures and combinations’ delayed effect mainly follows a quadratic relationship with a time lag maximum of eight to eleven days for the upper limit, a decreasing linear relationship for the growth rate, and mixed results between the estimation of individual measure and combinations for the inflection point. While the time delay of the pandemic primarily increases for the individual measures over the model specifications, the combinations show a decreasing relationship. The results of the constants and controls are broadly consistent, indicating robust findings across model specifications. However, some important distinctions can be made, most notably between the estimations that do and do not include the various combinations of measures.

Table 3 shows the nonlinear mixed-effect regression results of the individual measures. Following Lauer et al. [18], we focus on presenting our results on the five-day incubation time.

On average, we have a total number of 37,297 cumulated confirmed cases, with an average growth rate of 21.2%. The time of inflection point is around 50 days after the first confirmed case of COVID-19. We find no statistically significant results pointing towards the impact of the individual measures on the upper asymptote, except for border closure, which correlates positively with the upper limit with around 657 cases. This relationship changes for a time delay of 15 days; here, we find a significant negative relationship between the school closure, ban of gathering, border closure, business shut-down, and the upper limit.

The individual measures indeed have a statistically significant impact on the growth rate. For example, a risk area travel ban is associated with a decrease in the growth rate by 2.1 percentage points, while the ban of gatherings leads to a reduction of 2.7 percentage points. Closing borders and businesses are also negatively associated with daily growth rates of infection: closing of borders is found to decrease the growth rate by 5.6 percentage points. In comparison, closing businesses is related to a decrease of around 3 percentage points. National curfews lead to an average decrease in growth rate by 0.9 percentage points. A significant negative relationship between school closure and the growth rate can be found for an eight- and eleven-time delay.

In addition, closing borders and businesses and closing schools have a statistically significant impact on the time of the inflection point: Closing borders and business is associated with a postponement of the inflection point by three and one days, respectively, while school closing leads to a preponement of approximately three to four days.

Table 4 shows the nonlinear mixed-effect regression results of the combinations of individual measures. The signs and relative magnitudes of the constants and control variables suggest that the estimations of the individual measures are consistent with the analyses of the combinations of measures. We also find no statistical significance of the combinations of measures on the upper asymptote. Though, a time delay of eleven to fifteen days shows a positive relationship between the combinations and cumulated number of confirmed cases.

However, the combinations of measures are negatively associated with the growth rate. This significant effect increases with the number of individual measures included in the combinations. While the combination of risk area travel bans, school closures, bans of gatherings, and border closure leads to a decrease in the growth rate by 10.3 percentage points, the combination of all individual measures (including a national curfew) reduces the growth rate of confirmed COVID-19 cases by 16.4 percentage points. This same combination is associated with a postponement of the inflection point by 13 days. In addition, the combinations of "risk area travel bans, school closures, bans of gatherings, closed borders" and "risk area travels bans, school closures, bans of gatherings, closed borders, business closures" postpone the inflection point by 7.7 days and 8.3 days, respectively.

The results of control variables are broadly consistent within the models and specifications. The population size increases the upper asymptote and delays the inflection point; a one percent deviation from the mean increases the upper asymptote by 21,277 confirmed cases and delays the inflection point by seven days. The number of daily tests shows no economically significant results. While the rapid response index has a significant positive relationship with the upper limit, the health system index shows the contrary effect. Both correlate with a delay of the inflection point. An increase of 10 points in the indexes is associated with a delay of around five days.

The reduction of the growth rate and postponement of the peak can facilitate the containment of the COVID-19 pandemic and, thus, ease any overload of healthcare systems’ capacity. Following the Centers for Disease Control and Prevention [35], we examine the benefits of the containment measures against the COVID-19 pandemic and show the "flatten the curve" graphs for a time delay of five days in Fig 2 (for individual measures) and Fig 3 (for combinations of measures). The results show that individual measures can reduce daily cases’ peak by up to 490 cases on average (see Fig 2). For example, implementing a gathering ban reduces the daily cases’ peaks by 234 cases while border closure reduces 490 cases. This effect is even more substantial when measures are combined. Here, the peak decreases by up to 1,205 cases on average (see Fig 3). While implementing a risk area travel ban only delays daily cases’ peak by five days, the combination of measures delays 13 days.

Fig 2. Flatten the curve—The effect of individual measures on the containment of the COVID-19 pandemic (incubation of 5 days).

Fig 3. Flatten the curve—The effect of combinations of measures on the containment of the COVID-19 pandemic (incubation of 5 days).

In summary, it can be stated that all individual measures significantly decrease the daily growth rates of coronavirus cases. Moreover, the various combinations of these measures and the combinations of all measures significantly decrease the growth rates of confirmed cases, outweighing the individual measures’ growth rates. Particular measures not only decrease but also postpone the peak of infection of new COVID-19 cases.

Concluding remarks

Governments worldwide are searching for policies to respond to the ongoing outbreak of the COVID-19 pandemic caused by the severe acute respiratory syndrome, coronavirus 2 (SARS-CoV-2) [36]. These policy measures aim to advance the containment of the spread of the COVID-19 pandemic by reducing social contact among individuals within or between populations [37]. Among others, these social distancing policies include restricting travel, closing schools, and restricting populations to their homes through a complete lockdown [38]. Using data from six countries (China, South Korea, Italy, Iran, France, and the United States), Hsiang et al. [39] have simulated that the combined effect of policies within each country prevented or delayed the growth rate of infections by approximately 61 million confirmed cases and thus, significantly slowed the outbreak of the pandemic in these countries. However, the actual effects of these policies and measures on infection rates worldwide during this ongoing coronavirus pandemic need to be investigated.

Using data from 68 countries, Puerto Rico and the 50 federal states of the United States of America, four federal states of Australia, and eight federal states of Canada, covering 6,941 daily observations between January 22 and May 24, 2020, we show that federal policies have been effective in containing the spread of the COVID-19 pandemic. We show that all individual measures (i.e., school closures, shut-downs of non-essential businesses, mass gathering bans, travel restrictions in and out of risk areas, national border closures and/or complete entry bans, and nationwide curfews) significantly decrease the growth rate of confirmed cases. However, combinations of these measures outweigh the effects of the individual measures. Thus, combinations of policies are the most suitable means for significantly slowing both the regional and the global outbreak of the coronavirus.

Despite the range of unique results and recommendations outlined by this study, our work suffers from several limitations. One concern pertains to the data itself. Countries and states report confirmed COVID-19 cases that have been formerly tested and identified as corona-positive. However, these reported numbers do not represent the "real" numbers of infections and only show the cases that tests have positively confirmed. Thus, asymptomatic infected people and patients having COVID-19 but not being sent to testing are not part of the statistics of the confirmed cases. Additional studies [17, 4042] have used machine learning techniques to simulate the "real" number of COVID-19 cases. All models have produced valid results to conclude that the number of "real" infections far outnumber the reported confirmed cases. Nevertheless, they all follow the same growth curve of the COVID-19 pandemic and confirm the growth rate and inflection point but differ in the upper limit.

The number of hospitalized cases in intensive care units instead of cumulative confirmed cases could also be used as a substitute measure. This variable could represent an adequate robustness test as the COVID-19 intensive care unit patients are related to the number of cases but independent of the number of tested people.

Additionally, we observe the proliferation of the SARS-CoV-2 virus until the end of May 2020. As the COVID-19 pandemic is still ongoing and prevalent across countries, future studies could extend the time frame and include periods before introducing vaccinations. Our analysis also assumes that the implemented measures have the same impact in observed countries and states. Several studies have shed light on the differences in compliance with measures dependent on the stage of the COVID-19 pandemic [43], the trust in the health care system [44], or country differences [45]. Furthermore, we "only" observe measures implemented by the government and law institutions. Still, social norms, cultural differences, and behavioral recommendations can also be effective interventions for containing the spread of the COVID-19 pandemic. Consequently, future studies could focus on experiments and surveys that explain the compliance of non-law policies and non-pharmaceutical interventions in the population.

In summary, non-pharmaceutical interventions can be an effective measure for containing the spread of the COVID-19 pandemic. Therefore, health offices can apply measures such as social distancing and travel restrictions to decelerate the proliferation of the SARS-CoV-2 virus and, thus, "flatten the curve".


  1. 1. World Health Organization. Pneumonia of unknown cause–China, (Emergencies preparedness, response; Disease outbreak news). Retrieved from Accessed 5 January 2020.
  2. 2. John Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Retrieved from Accessed 24 May 2020.
  3. 3. Zhao S., Lin Q., Ran J., Musa S. S., Yang G., Wang W., et al. (2020). Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. International Journal of Infectious Diseases. 2020;92:214–217. pmid:32007643
  4. 4. Wu J. T., Leung K., & Leung G. M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet. 2020;395(10225):689–697. pmid:32014114
  5. 5. Bogoch I. I., Watts A., Thomas-Bachli A., Huber C., Kraemer M. U., & Khan K. (2020). Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel. Journal of Travel Medicine. 2020;27(2):taaa008. pmid:31943059
  6. 6. Santos J. (2020). Reflections on the impact of "flatten the curve" on interdependent workforce sectors. Environment Systems and Decisions. 2020;1–4.
  7. 7. Desai A. N., Kraemer M. U., Bhatia S., Cori A., Nouvellet P., Herringer M., et al. Real-time Epidemic Forecasting: Challenges and Opportunities. Health security. 2020;17(4):268–275.
  8. 8. Polonsky J. A., Baidjoe A., Kamvar Z. N., Cori A., Durski K., Edmunds W. J., et al. Outbreak analytics: a developing data science for informing the response to emerging pathogens. Philosophical Transactions of the Royal Society B. 2019;374(1776):20180276. pmid:31104603
  9. 9. Kaplan, J., Frias, L. & McFall-Johnsen, M. A third of the global population is on coronavirus lockdown—here’s our constantly updated list of countries and restrictions (Business Insider Coronavirus live updates) Accessed 14 April 2020.
  10. 10. Houeix, R. Lifting lockdown: France looks ahead to options for easing coronavirus restrictions (France24 Coronavirus notice) Retrieved from Accessed 4 April 2020.
  11. 11. Dong E., Du H., & Gardner L. (2020). An interactive web-based dashboard to track COVID-19 in real time. The Lancet infectious diseases, 20(5), 533–534. pmid:32087114
  12. 12. WHO (2020). Situation report– 50. Coronavirus disease 2019 (COVID-19) Accessed 9 March 2020.
  13. 13. Reuters (2020): French coronavirus cases jump above China’s after including nursing home tally. Accessed 25 April 2021.
  14. 14. Hasell J., Mathieu E., Beltekian D., Macdonald B., Giattino C., Ortiz-Ospina E., et al. (2020). A cross-country database of COVID-19 testing. Scientific data, 7(1), 1–7.
  15. 15. WHO (2020): Laboratory testing strategy recommendations for COVID-19. Accessed 25 April 2021.
  16. 16. Byambasuren O., Cardona M., Bell K., Clark J., McLaws M. L., & Glasziou P. (2020). Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada, 5(4), 223–234.
  17. 17. Russell T. W., Golding N., Hellewell J., Abbott S., Wright L., Pearson C. A., et al. (2020). Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections. BMC medicine, 18(1), 1–9.
  18. 18. Lauer S. A., Grantz K. H., Bi Q., Jones F. K., Zheng Q., Meredith H. R., et al. (2020). The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of internal medicine, 172(9), 577–582. pmid:32150748
  19. 19. Lee S. Y., Lei B., & Mallick B. (2020). Estimation of COVID-19 spread curves integrating global data and borrowing information. PloS one, 15(7), e0236860. pmid:32726361
  20. 20. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., et al. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England journal of medicine, 382:1199–1207. pmid:31995857
  21. 21. Linton N. M., Kobayashi T., Yang Y., Hayashi K., Akhmetzhanov A. R., Jung S. M., et al. (2020). Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. Journal of clinical medicine, 9(2), 538. pmid:32079150
  22. 22. Wang W., Artois J., Wang X., Kucharski A. J., Pei Y., Tong X., et al. (2020). Effectiveness of live poultry market interventions on human infection with avian influenza A (H7N9) virus, China. Emerging infectious diseases, 26(5), 891. pmid:32141425
  23. 23. Darvishian M., Dijkstra F., van Doorn E., Bijlsma M. J., Donker G. A., de Lange M. M., et al. (2017). Influenza vaccine effectiveness in the Netherlands from 2003/2004 through 2013/2014: the importance of circulating influenza virus types and subtypes. PloS one, 12(1), e0169528. pmid:28068386
  24. 24. Lee N., Chan P. K., Hui D. S., Rainer T. H., Wong E., Choi K. W., et al. (2009). Viral loads and duration of viral shedding in adult patients hospitalized with influenza. The Journal of infectious diseases, 200(4), 492–500. pmid:19591575
  25. 25. Duval A., Obadia T., Martinet L., Boëlle P. Y., Fleury E., Guillemot D., et al. (2018). Measuring dynamic social contacts in a rehabilitation hospital: effect of wards, patient and staff characteristics. Scientific Reports, 8(1), 1–11.
  26. 26. Dinh L., Chowell G., & Rothenberg R. (2018). Growth scaling for the early dynamics of HIV/AIDS epidemics in Brazil and the influence of socio-demographic factors. Journal of theoretical biology, 442, 79–86. pmid:29330056
  27. 27. Chong K. C., Ran J., Lau S. Y. F., Goggins W. B., Zhao S., Wang P., et al. (2021). Limited role for meteorological factors on the variability in COVID-19 incidence: A retrospective study of 102 Chinese cities. PLoS neglected tropical diseases, 15(2), e0009056. pmid:33626051
  28. 28. Breslow N.E., & Clayton D.G. Approximate inference in generalized linear mixed models. Journal of the American Statistical Association. 1993;88(421):9–25.
  29. 29. Kamrujjaman M., Mahmud M. S., & Islam M. S. Coronavirus outbreak and the mathematical growth map of Covid-19. Annual Research & Review in Biology. 2020;72–78.
  30. 30. Liang K. Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS. Infection, Genetics and Evolution, 2020;104306. pmid:32278147
  31. 31. Roosa K., Lee Y., Luo R., Kirpich A., Rothenberg R., Hyman J. M., et al. Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020. Infectious Disease Modelling, 2020;5:256–263. pmid:32110742
  32. 32. Bates D. M., & Pinheiro J. C. Model Building for Nonlinear Mixed Effects Models. Madison, WI: University of Wisconsin, Department of Biostatistics; 1994.
  33. 33. Wooldridge, JM 2013, Introductory Econometrics. A Modern Approach, South-Western Cengage Learning, Mason, Ohio; 2013.
  34. 34. Frick B. & Kaimann D. The impact of customer reviews and advertisement efforts on the performance of experience goods in electronic markets. Applied Economics Letters. 2016;24(17):1237–1240.
  35. 35. Centers for Disease Control and Prevention. Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States: early, targeted, layered use of non-pharmaceutical interventions. Retrieved from Accessed 9 October 2020.
  36. 36. Wu F., Zhao S., Yu B., Chen Y. M., Wang W., Song Z. G., et al. (2020). A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269. pmid:32015508
  37. 37. Kraemer M. U., Yang C. H., Gutierrez B., Wu C. H., Klein B., Pigott D. M., et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020;368(6490):493–497. pmid:32213647
  38. 38. Chinazzi M., Davis J. T., Ajelli M., Gioannini C., Litvinova M., Merler S., et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395–400. pmid:32144116
  39. 39. Hsiang S., Allen D., Annan-Phan S., Bell K., Bolliger I., Chong T., et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature. 2020;584(7820):262–267. pmid:32512578
  40. 40. Gu, Y. (2020). COVID-19 projections using machine learning. Retrieved May 29, 2020.
  41. 41. MRC Center (2020). Future scenarios of the healthcare burden of COVID-19 in Low- or Middle-Income Countries. Accessed 25 April 2021.
  42. 42. IHME (2020). COVID-19 Projections. Accessed 25 April 2021.
  43. 43. Banerjee R., Bhattacharya J., & Majumdar P. (2021). Exponential-growth prediction bias and compliance with safety measures related to COVID-19. Social Science & Medicine, 268, 113473. pmid:33130402
  44. 44. Chan H. F., Brumpton M., Macintyre A., Arapoc J., Savage D. A., Skali A., et al. (2020). How confidence in health care systems affects mobility and compliance during the COVID-19 pandemic. PloS one, 15(10), e0240644. pmid:33057450
  45. 45. Daoust J. F., Bélanger É., Dassonneville R., Lachapelle E., Nadeau R., Becher M., et al. (2021). A guilt-free strategy increases self-reported non-compliance with COVID-19 preventive measures: Experimental evidence from 12 countries. PloS one, 16(4), e0249914. pmid:33882102